Paper Details

  1. Home
  2. Paper Details

Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.

Author: AntonarakisEmmanuel S, AparicioAna M, ArmstrongAndrew J, AttardGerhardt, BeerTomasz M, BeltranHimisha, BjartellAnders, BlanchardPierre, BossiAlberto, BrigantiAlberto, BristowRob G, BulbulMuhammad, CaffoOrazio, CastellanoDaniel, CastroElena, ChengHeather H, ChiKim N, ChowdhurySimon, ClarkeCaroline S, ClarkeNoel, DaugaardGedske, DavisIan D, De SantisMaria, DuranIgnacio, EelesRoss, EfstathiouEleni, EfstathiouJason, EkekeOnyeanunam Ngozi, EvansChristopher P, FantiStefano, FengFelix Y, FizaziKarim, FonteyneValerie, FossatiNicola, FrydenbergMark, GeorgeDan, GillessenSilke, GleaveMartin, GravisGwenaelle, HalabiSusan, HeinrichDaniel, HerrmannKen, HiganoCelestia, HofmanMichael S, HorvathLisa G, HussainMaha, JamesNicholas D, Jereczek-FossaBarbara A, JonesRob, KanesvaranRavindran, Kellokumpu-LehtinenPirkko-Liisa, KhauliRaja B, KlotzLaurence, KramerGero, LeibowitzRaja, LogothetisChristopher, MahalBrandon, MalufFernando, MateoJoaquin, MathesonDavid, MehraNiven, MerseburgerAxel, MorgansAlicia K, MorrisMichael J, MottetNicolas, MrabtiHind, MukherjiDeborah, MurphyDeclan G, MurthyVedang, NguyenPaul L, O'SullivanJoe M, OhWilliam K, OmlinAurelius, OstPiet, PadhaniAnwar R, PezaroCarmel J, PoonDarren M C, PritchardColin C, RabahDanny M, RathkopfDana, ReiterRobert E, RubinMark A, RyanCharles J, SaadFred, SadeJuan Pablo, SartorOliver, ScherHoward I, SharifiNima, ShoreNeal, SkonecznaIwona, SmallEric, SmithMatthew, SouleHoward, SprattDaniel E, SrinivasSandy, SternbergCora N, SteuberThomas, SuzukiHiroyoshi, SweeneyChristopher J, SydesMatthew R, TaplinMary-Ellen, TilkiDerya, TombalBertrand, TurcoFabio, TürkeriLevent, UemuraHiroji, UemuraHirotsugu, ValeClaire L, VapiwalaNeha, WalzJochen, YamoahKosj, YeDingwei, YuEvan Y, ZapateroAlmudena, ZilliThomas, de BonoJohann, van OortInge, ÜrünYüksel

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Despite advances in treatment, there is still a lack of high-level evidence to guide clinical practice decisions for advanced prostate cancer. The 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) addressed specific questions in these areas.
Paper Details　
Original Abstract of the Article :
Innovations in imaging and molecular characterisation together with novel treatment options have improved outcomes in advanced prostate cancer. However, we still lack high-level evidence in many areas relevant to making management decisions in daily clinical practise. The 2022 Advanced Prostate Canc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ejca.2023.02.018

データ提供：米国国立医学図書館（NLM）

Navigating the Complexities of Advanced Prostate Cancer: A Consensus Conference Report

The landscape of [advanced prostate cancer] is constantly evolving, with new diagnostic tools and treatment options emerging. This report summarizes the findings of the [Advanced Prostate Cancer Consensus Conference (APCCC) 2022], which addressed key management challenges in the care of patients with [metastatic] and [castration-resistant prostate cancer]. The authors discuss the need for additional research and consensus on key areas of clinical practice to optimize patient care.

A Collaborative Approach to Advanced Prostate Cancer Management

This report highlights the importance of a collaborative approach to managing [advanced prostate cancer]. The [APCCC] serves as a platform for bringing together experts to address critical issues and refine best practices. The findings of this conference offer valuable guidance for healthcare professionals seeking to optimize patient care in this complex setting.

Improving Outcomes for Advanced Prostate Cancer Patients

The desert of [advanced prostate cancer] treatment is vast and challenging, but this report provides a roadmap for improving patient outcomes. The [APCCC] findings emphasize the need for continued research and collaboration to ensure that patients receive the most appropriate and effective care.

Dr.Camel's Conclusion

The journey through the desert of advanced prostate cancer is a difficult one, but the APCCC 2022 provides a valuable guide for navigating this complex landscape. The collaborative efforts of experts in this field offer a beacon of hope for patients seeking optimal care and improved outcomes.

Date :
  1. Date Completed 2023-05-16
  2. Date Revised 2023-05-18
Further Info :

Pubmed ID

37003085

DOI: Digital Object Identifier

10.1016/j.ejca.2023.02.018

Related Literature

Article Analysis
・Side Effects of abiraterone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.